Shilo has 15 years of experience in several management positions in the health industry. His experience spans both the establishment and management of startups from the very initial stages including business development and fundraising. Amongst these companies, Shilo was co-founder of LabStyle Innovation, where he served as President and COO. He was responsible for propelling the company’s flagship product “Dario” from inception to reality and led the company’s evolution to a public American company (OTC).
Together with being Smartzyme's CEO and CO-Founder, Shilo is also CO-Founder of Emendo Biotherapeutics ,that developing next generation gene editing tools for genetic disorders, and addressing the current technological gaps for realizing the promise of gene therapy, Orbimed is also lead investor in this company. Finally, Shilo is chairman of Mybiotics Pharma, a life science company developing live bacteria-based probiotic products to improve health and quality of life. The company has developed MyCrobe™ – a proprietary innovative live bacteria delivery system.
Shilo’s early career included key positions in MEX – an agency of medical experts; GmbH, a Germany-based consultancy agency engaged in building market infrastructure, introduction and assimilation of medical technologies in the German medical market; Three Wire, a US agency engaged in the recruitment and enrollment of patients into clinical trials; and CEO of D-Cure, a research fund sponsoring technologically-oriented medical research.